Liquidity & Technicals

Liquidity & Technicals

The tape says one thing the fundamentals do not yet: a heavy buyer arrived in late April 2026 — a single 23.6 million-share print, 33× normal turnover, on a stock with a sub-million-share daily baseline. That print bought a short-term momentum reversal (RSI 58, MACD line crossed back above signal, +18% in one month) but did not repair the primary trend: price still sits 12% below the 200-day SMA, the 50/200 SMA death cross from January 2026 is intact, and the 52-week range position is only the 39th percentile. The structurally interesting question for a PM is whether that block was an institutional accumulator stepping in near the 270 lows, or the bid-side of a single rotational trade. Stance: neutral leaning bearish until the 200-day at ₹400 reclaims, with ₹270 as the clean invalidation below. Liquidity is the real constraint here — not pricing — and is described in detail below.

1. Portfolio implementation verdict

5-day Capacity (20% ADV, ₹ Cr)

56.9

Largest Pos. % Mcap in 5d (20% ADV)

1.10

Supported Fund AUM, 5% Wt (₹ Cr)

1,138

ADV 20d / Mcap (%)

1.09

Tech Score (−6 to +6)

-2

2. Price snapshot

Current Price (₹)

352.20

YTD Return (%)

-18.1

1-Year Return (%)

-12.6

52w Range Position (pct)

39.2

30d Realized Vol (%)

57.1

The stock has retraced to the 39th percentile of its 52-week range (high ₹478.75, low ₹270.75), is down 18% YTD and 12.6% over twelve months, and is trading at a 30-day realized volatility of 57% — well above its 5-year 80th percentile of 47%. Beta versus the local benchmark is not estimable from this run; the realized-vol read is the better risk handle.

3. The critical chart — 10 years, price vs 50/200 SMA

Loading...

Price is below the 200-day SMA by 12% (₹352.20 vs ₹400.72). The regime is a downtrend within a 7-year sideways range bounded by ₹270 (the 2020 COVID low and the recent 52-week low) and ₹600 (the July 2024 high). The all-time high of ₹699 was set in 2018 and has not been retested in eight years; the 2024 push topped out 14% below it and rolled over.

4. Relative strength

Benchmark series (INDA — broad-market India ETF — and a sector overlay) were not retrievable for this run. A direct relative-strength chart against the local market is not estimable here. As a substitute reference, the company's own 3-year price action (visible in the main chart above) shows that Sunteck has cycled between ₹280 and ₹600 over that period and currently sits in the lower third of that range — directionally consistent with a stock that has lagged, not led, the broader Indian small-cap real estate move.

5. Momentum — RSI and MACD

Loading...
Loading...

Near-term momentum is constructive but not extreme. RSI bottomed at 21 in mid-March 2026 (a deeply oversold reading) and has rallied back to 58 — a textbook reset. MACD histogram has flipped firmly positive (+6.3 today, after −8 a month ago); the line/signal cross occurred in early April. This is a tradeable reversal in a still-broken trend, not a confirmed regime shift. Both indicators have fired similar bounce signals five times in the last 18 months without producing a sustained uptrend.

6. Volume, sponsorship, and the volatility regime

Loading...

Top three volume spikes — institutional footprints, not retail euphoria.

No Results

The 22 April 2026 print is the largest single-day volume in a decade and yet produced only a +4.9% close — typical of a negotiated block crossing or large institutional accumulator rather than a retail momentum chase. The earlier July 2023 spike (27× ADV, +12% close) coincided with a clean breakout rally; the recent print is less directionally violent. Reading: someone is patient.

Loading...

Realized volatility at 57% sits above the 5-year 80th percentile (47%), i.e. the stressed regime. The market is demanding a wider risk premium right now; option-pricing assumptions need to be calibrated to that, and any gap-risk hedge becomes more expensive. The trend-confirmation read is mixed: volume on the recent rally (ex the 22 April block) is below the 50-day average, which is not the signature of healthy accumulation.

7. Institutional liquidity panel

This is the section that determines whether the rest of the report is actionable. Sunteck has a market cap of ₹5,170 Cr (~₹51.7B), trading at a 20-day ADV of ₹56.6 Cr — but that ADV is materially inflated by the 22 April block trade (33× normal). On the more representative 60-day ADV of ₹23 Cr, the picture tightens significantly.

A. ADV and turnover

ADV 20d (M shares)

1.62

ADV 20d Value (₹ Cr)

56.6

ADV 60d (M shares)

0.65

ADV 20d / Mcap (%)

1.09

Annual Turnover, 60d basis (%)

111

ADV-20d shows a deceptively healthy 1.09% of market cap. ADV-60d, before the spike, was 0.44% — closer to the truth. Annual turnover on the 60-day basis is 111% of shares outstanding, which sounds high but reflects a relatively concentrated promoter base trading a small public float intensively rather than a truly liquid issue.

B. Fund-capacity table (the one that matters)

No Results

A fund of ₹500 Cr (~$53M) can take a 5% position cleanly at 10% ADV in five days. A fund of ₹1,140 Cr (~$120M) can do the same only at the more aggressive 20% ADV — and that footprint will be visible to the rest of the market within a day.

C. Liquidation runway

No Results

A 1% issuer-level stake (₹52 Cr) takes 5 trading days to exit at 20% ADV using inflated 20-day ADV; on the more honest 60-day basis it takes 12 days at 20% participation, 23 days at 10%. A 2% stake on the 60-day basis is essentially a month-long unwind at aggressive participation. For most institutional mandates, anything above 1% of the float should be sized as a multi-week build-and-bleed, not a single block.

D. Price-range proxy (impact cost)

The 60-day median daily range is 4.18% — well above the 2% threshold that signals elevated impact cost. Combined with the 4.5% daily ATR-implied move, market orders at meaningful size will move the print materially. Use VWAP / TWAP algos with strict participation caps; avoid market-on-close.

Bottom line on liquidity: the largest issuer-level position that clears in five days is 1.10% of market cap at 20% ADV (using inflated 20-day ADV) or 0.44% at 10% ADV (60-day basis). For a fund running 5% concentration, the practical capacity is approximately ₹450–1,140 Cr ($48–121M) of AUM. Above that, this becomes a watchlist or specialist-only name.

8. Technical scorecard and stance

No Results

Net score: −2 (neutral leaning bearish).

Stance — 3-to-6 month horizon

The primary read is bearish-with-a-bounce. The death cross of 15 January 2026 has not been repaired, price remains 12% below the 200-day SMA, the 52-week low at ₹270 was tested only six weeks ago, and realized volatility is in the stressed regime. Against that, RSI has reset from a 21 oversold print, MACD has crossed back above signal, and a 33× ADV block on 22 April suggests at least one institutional sponsor is willing to absorb size near the lows. The right tactical call is to wait for confirmation rather than to anticipate it.

Two specific levels:

  • Above ₹400 (200-day SMA): a daily close above this level on rising volume confirms the regime has shifted from down to mixed, validates the recent block-trade thesis, and would make a build defensible. This is the level that turns the rally into a reversal.
  • Below ₹270 (52-week low): a clean break of the March 2026 low invalidates the bounce, retests the multi-year ₹270 floor, and would force a re-rate of the stock toward its 2020 COVID lows in the ₹160–200 range. This is the line that says the bounce was a dead-cat exit for a larger seller.

Liquidity is the constraint, not the price action. For mandates above ~₹1,200 Cr (~$130M) AUM, this is a watchlist-only name regardless of where the chart goes; the build-window is too long to reflect a high-conviction view in a portfolio. Below that threshold, the right action is to wait for the 200-day reclaim on volume before adding, and to size as a 2–3% position rather than 5% to preserve the ability to exit cleanly in a stressed tape.